PTRH2 and lung adenocarcinoma: Bit1 expression is reduced in non-small cell lung carcinoma tumors and exogenous Bit1 overcomes anoikis resistance in human lung adenocarcinoma cells via caspase-independent pathways by prohibiting anchorage-independent growth (13).